Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01657474 · ClinicalTrials.gov registry record · NA
Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01657474 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 40 participants.
The verdict
NCT01657474, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a weekly application of EpiFix human amniotic membrane is more effective than a biweekly application (every two weeks) in the treatment of diabetic foot ulcers.
Interventions
- OTHER Weekly application of EpiFix plus standard of care
- OTHER Biweekly application of EpiFix plus standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01657474
The ClinicalTrials.gov registry entry for NCT01657474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Weekly application of EpiFix plus standard of care is the first listed.
NCT01657474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01657474 about?
NCT01657474 is a clinical study titled "Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers". The purpose of this study is to determine whether a weekly application of EpiFix human amniotic membrane is more effective than a biweekly application (every two weeks) in the treatment of diabetic foot ulcers.
What is the current status of trial NCT01657474?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-09. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01657474?
The interventions under investigation include: Weekly application of EpiFix plus standard of care (OTHER), Biweekly application of EpiFix plus standard of care (OTHER).
Who is sponsoring clinical trial NCT01657474?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.